Inflammation, Depression Severity, and Response to Ketamine in Treatment-Resistant Depressed Patients: Sex Differences

被引:0
|
作者
Kruse, Jennifer [1 ]
Hellemann, Gerhard [1 ]
Olmstead, Richard [1 ]
Jiang, Janina [1 ]
Congdon, Eliza [1 ]
Espinoza, Randall [1 ]
Narr, Katherine [1 ]
Irwin, Michael [1 ]
机构
[1] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
Inflammation; Depression; Ketamine; Sex Differences;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
M81
引用
收藏
页码:120 / 120
页数:1
相关论文
共 50 条
  • [21] Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
    Haile, C. N.
    Murrough, J. W.
    Iosifescu, D. V.
    Chang, L. C.
    Al Jurdi, R. K.
    Foulkes, A.
    Iqbal, S.
    Mahoney, J. J., III
    De La Garza, R., II
    Charney, D. S.
    Newton, T. F.
    Mathew, S. J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (02): : 331 - 336
  • [22] Maintenance Ketamine Therapy for Treatment-Resistant Depression
    Archer, Shaina
    Chrenek, Carson
    Swainson, Jennifer
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2018, 38 (04) : 380 - 384
  • [23] Magnesium in Ketamine Administration in Treatment-Resistant Depression
    Gorska, Natalia
    Cubala, Wieslaw Jerzy
    Slupski, Jakub
    Wiglusz, Mariusz Stanislaw
    Galuszko-Wegielnik, Maria
    Kawka, Mateusz
    Grzegorzewska, Agata
    PHARMACEUTICALS, 2021, 14 (05)
  • [24] Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review
    Kwasny, Aleksander
    Wlodarczyk, Adam
    Ogonowski, Damian
    Cubala, Wieslaw Jerzy
    PHARMACEUTICALS, 2023, 16 (04)
  • [25] Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine
    Liu, Linda Xing Yu
    Golts, Marina
    Fernandes, Virginia
    PHARMACY, 2021, 9 (03)
  • [26] The Impact of Childhood Maltreatment on Intravenous Ketamine Outcomes for Adult Patients with Treatment-Resistant Depression
    O'Brien, Brittany
    Lijffijt, Marijn
    Wells, Allison
    Swann, Alan C.
    Mathew, Sanjay J.
    PHARMACEUTICALS, 2019, 12 (03)
  • [27] Interleukin-8 and lower severity of depression in females, but not males, with treatment-resistant depression
    Kruse, Jennifer L.
    Olmstead, Richard
    Hellemann, Gerhard
    Breen, Elizabeth C.
    Tye, Susannah J.
    Brooks, John O., III
    Wade, Benjamin
    Congdon, Eliza
    Espinoza, Randall
    Narr, Katherine L.
    Irwin, Michael R.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 140 : 350 - 356
  • [28] Intravenous subanesthetic ketamine: an innovative treatment option for rapid response in treatment-resistant depression
    Kang, M.
    Hawken, E.
    Bahji, A.
    Brietzke, E.
    Vazquez, G.
    EUROPEAN PSYCHIATRY, 2020, 63 : S113 - S113
  • [29] Sex Differences in a Double-Blind Randomized Clinical Trial With Minocycline in Treatment-Resistant Depressed Patients: CRP and IL-6 as Sex-Specific Predictors of Treatment Response
    Lombardo, Giulia
    Nettis, Maria Antonietta
    Hastings, Caitlin
    Zajkowska, Zuzanna
    Mariani, Nicole
    Nikkheslat, Naghmeh
    Worrell, Courtney
    Enache, Daniela
    McLaughlin, Anna
    Kose, Melisa
    Sforzini, Luca
    Bogdanova, Anna
    Cleare, Anthony J.
    Young, Allan H.
    Mondelli, Valeria
    Pariante, Carmine M.
    BIOLOGICAL PSYCHIATRY, 2022, 91 (09) : S205 - S206
  • [30] Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study
    Nugent, Allison C.
    Wills, Kathleen E.
    Gilbert, Jessica R.
    Zarate, Carlos A., Jr.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2019, 283 : 64 - 66